drugset / Trial / NCT01635777
Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)
RandomizedParallel-groupOpen-labelTreatment
Summary
Miltefosine efficacy will be \>85%
Timeline
- Start
- 2007-07
- Primary completion
- 2009-10
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Miltefosine | Small molecule | 2.5 mg/kg | Oral |
Indications
No indication recorded.